mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |